{"filing":{"accession_number":"0001193125-26-352229","cik":"0000949858","ticker":"ACHV","company_name":"ACHIEVE LIFE SCIENCES, INC.","form":"8-K","filing_date":"2026-08-14","report_date":"2026-08-14","primary_document":"achv-20260814.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526352229/achv-20260814.htm"},"events":[{"id":27895,"run_id":25472,"accession_number":"0001193125-26-352229","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The Company entered into an at-the-market (ATM) offering agreement with Jefferies to sell up to $150 million of common stock. This is a dilutive equity issuance under an ATM program, which is a material capital-raising activity that would affect investor assessment of share dilution and the company's financing strategy. The filing explicitly discloses the Sales Agreement, the maximum offering amount, and intended use of proceeds for commercialization and clinical trials.","company_name":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":[{"id":29609,"accession_number":"0001193125-26-352229","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Company entered into an at-the-market (ATM) offering agreement with Jefferies to sell up to $150 million of common stock. This is a dilutive equity issuance under an ATM program, which is a material capital-raising activity that would affect investor assessment of share dilution and the company's financing strategy. The filing explicitly discloses the Sales Agreement, the maximum offering amount, and intended use of proceeds for commercialization and clinical trials.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T20:21:45.502351+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29609,"accession_number":"0001193125-26-352229","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Company entered into an at-the-market (ATM) offering agreement with Jefferies to sell up to $150 million of common stock. This is a dilutive equity issuance under an ATM program, which is a material capital-raising activity that would affect investor assessment of share dilution and the company's financing strategy. The filing explicitly discloses the Sales Agreement, the maximum offering amount, and intended use of proceeds for commercialization and clinical trials.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T20:21:45.502351+00:00","company_name":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","filing_date":"2026-08-14"}]}